Clinical trial
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With…
NCT00241254 · University Hospital, Bordeaux, Other · Completed
Key facts
| NCT number | NCT00241254 |
|---|---|
| Title | Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis |
| Official title | A Double-blind, Two-arm, Multicenter, Randomized Trial to Evaluate Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Recent Secondary Progressive Multiple Sclerosis: P.R.OM.E.S.S Study |
| Acronym | PROMESS |
| Lead sponsor | University Hospital, Bordeaux, Other |
| Collaborators | Ministry of Health, France |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis, Chronic Progressive |
| Intervention type | Drug |
| Interventions | Cyclophosphamide (drug), Methylprednisolone (drug) |
| Enrollment | 138 |
| Start date | Dec 1, 2005 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2012 |
| First posted | Oct 18, 2005 |
| Last update posted | Mar 15, 2012 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: